10 Best Fast Growth Stocks to Invest In Now
Fast-growth stocks are getting a fresh look as the market no longer only looks at a small group of mega-cap names.
Jazz Pharmaceuticals Plc (JAZZ)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Polaris Capital Management Bernard Horn | 415,366 | $78,524,942 | -4% | 6.42% |
| 2. | Bayforest Capital Theodoros Tsagaris | 291 | $55,014 | -80% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $103.00 | 1,621 | $166,961.54 | 101,621 | 2025-05-12 | Filing | |
| $99.71 | 100 | $9,971.00 | 100,000 | 2025-05-09 | Filing | |
| $98.91 | 19,216 | $1,900,677.62 | 99,900 | 2025-05-09 | Filing | |
| $98.10 | 80,684 | $7,915,471.55 | 80,684 | 2025-05-09 | Filing | |
| $119.65 | 12,000 | $1,435,800.00 | 27,932 | 2024-03-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $191.74 | 24 | $4,601.87 | 384,682 | 2026-04-01 | Filing | |
| $190.94 | 2,292 | $437,630.58 | 384,706 | 2026-04-01 | Filing | |
| $190.22 | 3,684 | $700,777.85 | 386,998 | 2026-04-01 | Filing | |
| $182.94 | 1,287 | $235,443.78 | 6,512 | 2026-03-09 | Filing | |
| $187.84 | 233 | $43,767.75 | 405,796 | 2026-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 488,661 | $92,381,362 | 0.76% | |
| 2. | 320,000 | $60,496,000 | 0.09% | |
| 3. | 169,265 | $31,999,548 | 0.11% | |
| 4. | 173,250 | $31,781,525 | 0.03% | |
| 5. | 160,006 | $30,249,134 | 0.56% |
News See All
Raymond James Resumes Coverage of Jazz Pharmaceuticals (JAZZ) With an Outperform Rating
Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the most undervalued biotech stocks to buy right now. On April 10, Raymond James resumed coverage of Jazz Pharmaceuticals (NASDAQ:JAZZ) with an Outperform...
8 Most Undervalued Biotech Stocks to Buy Right Now
On April 13, Tom Lee, Fundstrat's head of research, appeared on CNBC’s 'Power Lunch' to talk about his outlook on equities, what to expect in a wartime economy, and more.
Jazz Pharmaceuticals plc (JAZZ) Reports $1.2 Billion Q4 Revenue, Beats $1.17B Estimate
On February 25, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) reported Q4 revenue of $1.2 billion, exceeding consensus estimates of $1.17 billion and marking 10% year-over-year growth.
Is Jazz Pharmaceuticals (JAZZ) One of the Best Cheap Biotech Stocks to Buy Now?
Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the best cheap biotech stocks to buy now.
12 Cheap Biotech Stocks to Buy Now
On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
11 Best Pot Stocks to Buy According to Hedge Funds
The global cannabis industry is undergoing a structural transformation as legalization expands for both medical and adult use across multiple regions.
Jazz Pharmaceuticals plc (JAZZ) Jumps Nearly 30% on Strong Q3 and Cancer Drug Trial Progress
The Harbor Capital Advisors released its “Mid Cap Value Fund’s” Q4 2025 investor letter. A copy of the letter can be downloaded here.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals Fourth Quarter 2025 Earnings Conference Call.
Truist Securities Raises Jazz Pharmaceuticals (JAZZ) Price Target After HERIZON-GEA Trial
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) ranks among the mid-cap stocks to buy according to top investors.
Hedge Fund Resource Center